Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Original Article from The New England Journal of Medicine — Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Related Articles
The Power of Physicians in Dangerous Times | NEJM
The current crisis in the United States is bigger than politics, and it deeply affects the health and lives of our patients and communities. Now…
Longitudinal Changes in Airway Mucus Plugs and FEV1 in COPD | NEJM
Among patients with COPD, those with persistent or newly formed mucus plugs at 5-year follow-up had a greater decrease in lung function than those with…
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis | NEJM
Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral inflammation and persistent immune activation within the central nervous system,…
Case 14-2025: A 29-Year-Old Woman with Peritonsillar Swelling and Bleeding | NEJM
A 29-year-old woman was admitted to the hospital because of sore throat and peritonsillar swelling and bleeding. Symptoms did not abate with antimicrobial therapy. A…
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
Targeting Orexin Receptors to Treat Narcolepsy | NEJM
The author describes the scientific foundations of a trial of an orexin agonist to treat narcolepsy.
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis | NEJM
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis–associated organisms between partners suggests that ma…
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
Tolebrutinib versus Teriflunomide in Multiple Sclerosis | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Tolebrutinib versus Teriflunomide in Multiple Sclerosis